Bioleaders Corporation (142760) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.048x

Based on the latest financial reports, Bioleaders Corporation (142760) has a cash flow conversion efficiency ratio of -0.048x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.59 Billion ≈ $-1.08 Million USD) by net assets (₩33.09 Billion ≈ $22.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Bioleaders Corporation - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Bioleaders Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Bioleaders Corporation balance sheet liabilities for a breakdown of total debt and financial obligations.

Bioleaders Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioleaders Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Everest Metals Corporation Ltd AU:EMC	0.027x
Bluglass Ltd AU:BLG	0.000x
Celulosa Argentina SA BA:CELU	0.013x
UTSTARCOM HLDGS DL-0015 F:UT5	N/A
Wealth Minerals Ltd. V:WML	-0.251x
Minesto AB ST:MINEST	-0.002x
Japan Gold Corp V:JG	-0.042x
SHINWON CONSTRUCTION COMPANY Ltd KQ:017000	-0.084x

Annual Cash Flow Conversion Efficiency for Bioleaders Corporation (2015–2024)

The table below shows the annual cash flow conversion efficiency of Bioleaders Corporation from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 142760 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩37.31 Billion ≈ $25.28 Million	₩-501.75 Million ≈ $-340.03K	-0.013x	-107.80%
2023-12-31	₩35.79 Billion ≈ $24.26 Million	₩6.18 Billion ≈ $4.18 Million	0.173x	+118.16%
2022-12-31	₩21.69 Billion ≈ $14.70 Million	₩-20.60 Billion ≈ $-13.96 Million	-0.950x	-751.07%
2021-12-31	₩45.11 Billion ≈ $30.57 Million	₩-5.04 Billion ≈ $-3.41 Million	-0.112x	+37.04%
2020-12-31	₩30.60 Billion ≈ $20.74 Million	₩-5.43 Billion ≈ $-3.68 Million	-0.177x	-92.34%
2019-12-31	₩23.82 Billion ≈ $16.14 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.092x	+75.30%
2018-12-31	₩23.50 Billion ≈ $15.92 Million	₩-8.77 Billion ≈ $-5.94 Million	-0.373x	-53.95%
2017-12-31	₩35.17 Billion ≈ $23.83 Million	₩-8.53 Billion ≈ $-5.78 Million	-0.242x	+45.00%
2016-12-31	₩17.46 Billion ≈ $11.83 Million	₩-7.70 Billion ≈ $-5.22 Million	-0.441x	+49.32%
2015-12-31	₩5.55 Billion ≈ $3.76 Million	₩-4.83 Billion ≈ $-3.27 Million	-0.870x	--

About Bioleaders Corporation

KQ:142760 Korea Biotechnology

Market Cap

$20.99 Million

₩30.97 Billion KRW

Market Cap Rank

#24856 Global

#1845 in Korea

Share Price

₩793.00

Change (1 day)

-7.68%

52-Week Range

₩622.00 - ₩2190.00

All Time High

₩24990.00